Croda CEO discloses share award exercise and small share sale

Croda International ( (GB:CRDA) ) just unveiled an update.

Croda International has disclosed a share transaction by chief executive Stephen Edward Foots under regulatory rules covering dealings by senior managers. The move involved the exercise of a conditional performance share award and an immediate sale of part of the resulting shares on the London Stock Exchange.

Foots exercised a 2023 grant under the Croda Performance Share Plan at nil cost and sold a portion of the ordinary shares to cover the associated tax liability. The limited size of the transaction suggests it is an administrative step rather than a signal of a strategic shift, but it maintains transparency for investors regarding executive equity incentives and disposals.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £35.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Spark’s Take on CRDA Stock

According to Spark, TipRanks’ AI Analyst, CRDA is a Neutral.

The score reflects solid financial stability (manageable leverage and positive cash generation) and supportive technical momentum, balanced against a demanding valuation (high P/E) and execution risk highlighted on the earnings call (exceptional charges and segment volatility despite improving guidance and transformation progress).

To see Spark’s full report on CRDA stock, click here.

More about Croda International

Croda International is a U.K.-listed specialty chemicals group that manufactures high-value ingredients and materials for consumer care, life sciences, and performance technologies. The company focuses on supplying tailored chemical solutions to global industrial and consumer markets, with its shares traded on the London Stock Exchange.

Average Trading Volume: 559,271

Technical Sentiment Signal: Sell

Current Market Cap: £3.96B

Find detailed analytics on CRDA stock on TipRanks’ Stock Analysis page.